Form 4: ClearPoint Neuro Director Acquires Shares in Lieu of Fees
SEC Form 4 Filing
Pascal E. R. Girin, a director at ClearPoint Neuro, acquired 1,056 shares of common stock on April 1, 2024, as payment for director fees.
Summary
- On April 1, 2024, Pascal E. R. Girin, a director of ClearPoint Neuro, Inc. (CLPT), acquired 1,056 shares of common stock.
- The acquisition was made in lieu of cash payment for director fees under the company's Non-Employee Director Compensation Plan.
- The shares were issued at a price of $6.80, which was the closing price of CLPT's common stock on March 28, 2024.
- Following the transaction, Girin directly owns 55,044 shares of ClearPoint Neuro, Inc.
Sentiment
Score: 6
Explanation: Neutral sentiment as it reflects a routine transaction related to director compensation. It's a positive sign that the director is willing to take compensation in stock, but it's not a major event.
Positives
- The acquisition of shares by a director demonstrates confidence in the company.
- Using shares for compensation conserves the company's cash resources.
Industry Context
Director share acquisitions are common in publicly traded companies as part of compensation packages and can be seen as a sign of confidence in the company's future prospects. This is a standard practice for ClearPoint Neuro.
Comparison to Industry Standards
- Using equity as part of director compensation is a common practice among publicly traded companies, particularly in growth-oriented sectors like medical technology.
- Many companies in the medical device industry, such as Medtronic and Stryker, utilize stock options and restricted stock units as part of their director compensation packages to align director interests with shareholder value.
- The specific amount and structure of equity compensation vary based on company size, performance, and industry norms.
Related Party Transactions
- The issuance of shares to Pascal E. R. Girin, a director, is a related party transaction.
Stakeholder Impact
- Shareholders may view the director's stock acquisition positively as it aligns the director's interests with theirs.
- The company benefits from conserving cash by using shares for compensation.
Key Dates
| Date | Description |
|---|---|
| 03/28/2024 | Closing price of $6.80 used for share issuance. |
| 04/01/2024 | Date of transaction: Director acquired shares. |
| 04/02/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.